The vaccine in question is AstraZeneca (AZ) and the University of Oxford’s two-dose adenovirus vaccine candidate. This approval occurs in the context of an escalating Covid-19 crisis in the UK.

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...

AstraZeneca PLC AZN shares inched down 0.99% to £117.80 Friday, on what proved to be an all-around rough trading session for ...

In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Buy rating on AstraZeneca (AZN – Research Report), with a ...

AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank of America Securities maintained a Buy rating on ...

Oxford Vaccine Rollout At the very end of December, UK healthcare regulator the Medicines and Healthcare Products Regulatory ...

AstraZeneca PLC AZN shares inched up 0.74% to £120.16 Monday, on what proved to be an all-around positive trading session for ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

The study is testing a COVID-19 vaccine being developed by AstraZeneca and University of Oxford researchers at various sites, including the United Kingdom, where the adverse event was reported.

“Before Jack had his Oxford AstraZeneca Covid-19 injection, he hadn’t had a single day sick from work. He was very rarely unwell. Then suddenly he was not fine. It all happened so quickl ...

"Before Jack had his Oxford AstraZeneca COVID-19 injection, he hadn’t had a single day sick from work. "It all happened so quickly, it still struggles to hit home at times that we are never ...